216 related articles for article (PubMed ID: 2296310)
1. A transgenic mouse model of sickle cell disorder.
Greaves DR; Fraser P; Vidal MA; Hedges MJ; Ropers D; Luzzatto L; Grosveld F
Nature; 1990 Jan; 343(6254):183-5. PubMed ID: 2296310
[TBL] [Abstract][Full Text] [Related]
2. Correction of sickle cell disease in transgenic mouse models by gene therapy.
Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
[TBL] [Abstract][Full Text] [Related]
3. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
Ye L; Chang JC; Lu R; Kan YW
Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
[TBL] [Abstract][Full Text] [Related]
4. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
5. Mouse models of sickle cell disease.
Beuzard Y
Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
[TBL] [Abstract][Full Text] [Related]
6. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
[TBL] [Abstract][Full Text] [Related]
8. [Molecular and cellular pathophysiology of sickle cell anemia].
Labie D; Elion J
Pathol Biol (Paris); 1999 Jan; 47(1):7-12. PubMed ID: 10081773
[TBL] [Abstract][Full Text] [Related]
9. Genetic correction of sickle cell disease: insights using transgenic mouse models.
Blouin MJ; Beauchemin H; Wright A; De Paepe M; Sorette M; Bleau AM; Nakamoto B; Ou CN; Stamatoyannopoulos G; Trudel M
Nat Med; 2000 Feb; 6(2):177-82. PubMed ID: 10655106
[TBL] [Abstract][Full Text] [Related]
10. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
[TBL] [Abstract][Full Text] [Related]
11. Beta globin gene inhibition by antisense RNA transcripts.
Xu L; Ferry AE; Monteiro C; Pace BS
Gene Ther; 2000 Mar; 7(5):438-44. PubMed ID: 10694826
[TBL] [Abstract][Full Text] [Related]
12. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
Oh IH; Fabry ME; Humphries RK; Pawliuk R; Leboulch P; Hoffman R; Nagel RL; Eaves C
Exp Hematol; 2004 May; 32(5):461-9. PubMed ID: 15145214
[TBL] [Abstract][Full Text] [Related]
13. Monovalent cation changes in sickle erythrocytes: a direct reflection of alpha-globin gene number.
Embury SH; Backer K; Glader BE
J Lab Clin Med; 1985 Jul; 106(1):75-9. PubMed ID: 4009025
[TBL] [Abstract][Full Text] [Related]
14. Foetal haemoglobin levels in sickle cell anaemia in Nigerians.
Falusi AG; Esan GJ
Afr J Med Med Sci; 1989 Jun; 18(2):145-9. PubMed ID: 2474239
[TBL] [Abstract][Full Text] [Related]
15. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
[TBL] [Abstract][Full Text] [Related]
16. Raised Hb F levels in sickle cell disease are caused by a determinant linked to the beta globin gene cluster.
Kulozik AE; Thein SL; Kar BC; Wainscoat JS; Serjeant GR; Weatherall DJ
Prog Clin Biol Res; 1987; 251():427-39. PubMed ID: 2448811
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease.
Madigan C; Malik P
Expert Rev Mol Med; 2006 Apr; 8(9):1-23. PubMed ID: 16690007
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.
May C; Rivella S; Callegari J; Heller G; Gaensler KM; Luzzatto L; Sadelain M
Nature; 2000 Jul; 406(6791):82-6. PubMed ID: 10894546
[TBL] [Abstract][Full Text] [Related]
19. Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia?
Vekilov PG
Br J Haematol; 2007 Oct; 139(2):173-84. PubMed ID: 17897293
[TBL] [Abstract][Full Text] [Related]
20. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia.
Chang JC; Lu R; Lin C; Xu SM; Kan YW; Porcu S; Carlson E; Kitamura M; Yang S; Flebbe-Rehwaldt L; Gaensler KM
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14886-90. PubMed ID: 9843985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
